CellSeed Inc
TSE:7776
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Balurghat Technologies Ltd
BSE:520127
|
IN |
|
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
XETRA:EFF
|
DE |
|
P
|
Playfair Mining Ltd
OTC:PLYFF
|
CA |
|
G
|
GMR Power and Urban Infra Ltd
NSE:GMRP&UI
|
IN |
|
L
|
Lingsen Precision Industries Ltd
TWSE:2369
|
TW |
|
V
|
Vistar Amar Ltd
BSE:538565
|
IN |
|
S
|
SoftBank Group Corp
OTC:SFTBY
|
JP |
|
Bolt Projects Holdings Inc
NASDAQ:BSLK
|
US |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| JP |
|
CellSeed Inc
TSE:7776
|
10.6B JPY |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -179.8% |
| 30th Percentile | 21.8% |
| Median | 30.6% |
| 70th Percentile | 42.3% |
| Max | 18 197.9% |
Other Profitability Ratios
CellSeed Inc
Glance View
CellSeed Inc. develops regenerative medicine products. The company is headquartered in Koto-Ku, Tokyo-To and currently employs 44 full-time employees. The company went IPO on 2010-03-16. The firm operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for CellSeed Inc is 51.1%, which is below its 3-year median of 54.3%.
Over the last 3 years, CellSeed Inc’s Gross Margin has increased from 48.3% to 51.1%. During this period, it reached a low of 48.3% on Dec 31, 2022 and a high of 57.3% on Sep 30, 2024.
